# Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus

> **NCT02664740** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Centre Hospitalier Universitaire de Nīmes** · enrollment: 60 (estimated)

## Conditions studied

- Diabetic Foot
- Staphylococcal Infections

## Interventions

- **DRUG:** Topical anti-Staphylococcus bacteriophage therapy
- **DRUG:** Topical placebo corresponding to anti-Staphylococcus bacteriophage therapy

## Key facts

- **NCT ID:** NCT02664740
- **Lead sponsor:** Centre Hospitalier Universitaire de Nīmes
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-11
- **Final completion:** 2028-11
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02664740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02664740, "Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02664740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*